SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mike head who wrote (801)7/16/1999 7:39:00 PM
From: scaram(o)ucheRead Replies (1) of 4974
 
The thoughts are rather well publicized already, huh? Well, in that case, I hope that any lawsuits include punitive damages. Perhaps Pfizer should start salting away about a million per day? Restricted cash.

Seems like Pfizer is being sort of slow about the issue? How many patients might suffer from any lethargy? Do they need to pay an agency millions, or can they name it "Artharupt" and get on with it?

I could actually provide some interesting documents..... stuff that reflects, IMO, on Pfizer's respect for patients, on how careful they are before initiating a trial.

I'll wait a couple of weeks, but I think it would be worth the effort to open a thread devoted to Pfizer, ethics and toxicity.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News